| BCBS Oklahoma Medical Policies | Bioengineered Skin and Soft Tissue Substitutes | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Biomarker Testing in Risk Assessment and Management of | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Canakinumab | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Cerliponase alfa | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Collection and Storage of Umbilical Cord Blood Stem Cells | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Electrical Stimulation of the Spine as an Adjunct to Spinal | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Endoscopic Ultrasound-Guided Direct Hepatic Portosystemic | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Extracorporeal Shock Wave Treatment for Plantar Fasciitis and | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Givosiran for Acute Hepatic Porphyria | 2025-11-01 |
| BCBS Oklahoma Medical Policies | Interspinous and Interlaminar Stabilization/Distraction | 2025-11-01 |